Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections
Description
CONCLUSIONS AND RELEVANCE: These findings suggest that the use of either nirmatrelvir or molnupiravir is associated with reductions in mortality and hospitalization in patients infected with Omicron, regardless of age, race and ethnicity, virus
